Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2020-07-01
2020-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is a necessary part of the clinical evaluation process of the investigational device. The results of this study are used for the clinical evaluation, and for reporting of in-vivo repeatabilities in the instructions for use of the investigational device, as required by topography standards.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study - ES 900 - 2020-1
NCT05304182
Time Study for Biometry Measurements With the Lenstar and IntraOcularLens (IOL) Master 500
NCT01550939
Multicentric Clinical Study on Isatis TF Trifocal Intraocular Lens
NCT04465344
EDF IOL Versus Monofocal IOL
NCT07092020
A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction
NCT06594185
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Corneal topography is the act of measuring the shape of the cornea, in particular of the anterior cornea, but, depending on the device and the application, also of the posterior cornea, as well as the distance between the anterior to the posterior of the cornea. These measurements can be used in the context of ocular biometry, but are also useful for many other applications where knowledge of the optical and structural properties of the cornea are of interest.
Optical coherence tomography (OCT) is a well-established imaging modality in ophthalmology. It uses interferometry to obtain a scattering profile of the eye along the direction of propagation of a laser beam which is directed onto the eye. In analogy to ultrasound imaging, this scattering profile is called A-Scan. By laterally translating the measurement beam, several A-scans can be combined to form a 2-dimensional image or 3-dimensional (3D) tomogram of the eye. The main use of OCT is the cross-sectional imaging of the retina or the cornea, primarily for diagnostic purposes\[4\]. Recently, anterior segment OCT has also been used for corneal topography\[5\], as well as for biometry and cross-sectional imaging along the entire length of the eye\[6\].
EYESTAR 900 is a device developed by Haag-Streit which utilises 3D OCT for quantitative measurements of the geometry of the entire eye, including ocular biometry and corneal topography. CE approval for EYESTAR 900 with software version i9.4.0.0 is pending and expected before the start of this clinical trial.
The development of this device has been continued, and the following additions have been made in software version i9.5.1.0 used for this clinical study with respect to the software version i9.4.0.0:
* Extended corneal topography: corneal topography can be evaluated over an extended area (diameter of trajectory d=13mm with respect to d=8.6mm in "standard corneal topography").
* Irregularity segmentation: segmentation methods (identification of corneal surfaces) used in corneal topography now incorporate an improved algorithm for segmentation of irregular corneal surfaces.
* Irregularity visualization: visualization of topography maps has been supplemented by an overlay of regions with irregular corneal surfaces.
* Zone-based keratometry: visualization of topography maps has been further supplemented by an overlay of local keratometry values (power and axes of flat and steep meridians in the centre, middle and outer corneal surface).
* Crystalline lens tilt: the tilt of the crystalline lens normal vector with respect to the visual axis can be visualized and quantified.
Both irregularity visualization and zone-based keratometry are applicable to corneal topography data acquired with the standard corneal topography protocol, as well as corneal topography acquired over the extended area (diameter 13mm, extended corneal topography).
The primary objective of this clinical trial is to assess the clinical performance of extended corneal topography using irregularity segmentation, standard corneal topography using irregularity segmentation and crystalline lens tilt. To that end, for each measurand, the in-vivo repeatability will be quantified. For "standard corneal topography" and "extended corneal topography", the limits of agreement and the mean measurement deviation, with respect to three comparators are analyzed.
As a secondary objective of the study, raw measurement data will be collected to allow for the improvement of existing algorithms, development of additional measurands and for retrospective analysis.
Examinations with EYESTAR 900 and the other study devices are non-contact examinations. No diseases are studied as part of this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NORMAL
Normal group includes eyes with healthy cornea.
Haag-Streit EYESTAR 900
The EYESTAR 900 is a new device developed by HAAG-STREIT AG which utilises Optical Coherence Tomography (OCT) for quantitative measurements of the geometry of the eye. As a successor to the LENSTAR 900, it represents the most recent in a series of successful biometry devices.
Tomey CASIA 2
The CASIA2 is a testing application for Cataract / Glaucoma / Cornea Surgery already established on the market. It is a representative device for measurement of anterior and posterior corneal curvature (anterior and posterior corneal topography) by optical coherence tomography, and for measurement of crystalline lens tilt by optical coherence tomography.
Oculus PENTACAM HR
The Pentacam HR is a high-resolution rotating Scheimpflug camera system for anterior segment analysis already established on the market. It is used as representative device for advanced anterior segment analysis such as anterior and posterior corneal topography and corneal pachymetry.
Zeiss ATLAS 9000
ATLAS is a corneal topography system used as representative device for measurement of anterior corneal curvature (anterior corneal topography).
IRREGULAR
Irregular goup includes eyes with irregular astigmatism or corneal scarring.
Haag-Streit EYESTAR 900
The EYESTAR 900 is a new device developed by HAAG-STREIT AG which utilises Optical Coherence Tomography (OCT) for quantitative measurements of the geometry of the eye. As a successor to the LENSTAR 900, it represents the most recent in a series of successful biometry devices.
Tomey CASIA 2
The CASIA2 is a testing application for Cataract / Glaucoma / Cornea Surgery already established on the market. It is a representative device for measurement of anterior and posterior corneal curvature (anterior and posterior corneal topography) by optical coherence tomography, and for measurement of crystalline lens tilt by optical coherence tomography.
Oculus PENTACAM HR
The Pentacam HR is a high-resolution rotating Scheimpflug camera system for anterior segment analysis already established on the market. It is used as representative device for advanced anterior segment analysis such as anterior and posterior corneal topography and corneal pachymetry.
Zeiss ATLAS 9000
ATLAS is a corneal topography system used as representative device for measurement of anterior corneal curvature (anterior corneal topography).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Haag-Streit EYESTAR 900
The EYESTAR 900 is a new device developed by HAAG-STREIT AG which utilises Optical Coherence Tomography (OCT) for quantitative measurements of the geometry of the eye. As a successor to the LENSTAR 900, it represents the most recent in a series of successful biometry devices.
Tomey CASIA 2
The CASIA2 is a testing application for Cataract / Glaucoma / Cornea Surgery already established on the market. It is a representative device for measurement of anterior and posterior corneal curvature (anterior and posterior corneal topography) by optical coherence tomography, and for measurement of crystalline lens tilt by optical coherence tomography.
Oculus PENTACAM HR
The Pentacam HR is a high-resolution rotating Scheimpflug camera system for anterior segment analysis already established on the market. It is used as representative device for advanced anterior segment analysis such as anterior and posterior corneal topography and corneal pachymetry.
Zeiss ATLAS 9000
ATLAS is a corneal topography system used as representative device for measurement of anterior corneal curvature (anterior corneal topography).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* participants with healthy eyes,
* participants with corneal scarring,
* participants with irregular astigmatism.
Exclusion Criteria
* persons of vulnerable populations,
* persons unable or unwilling to follow instructions,
* persons unable to maintain fixation for the duration of the examinations,
* persons with active inflammation or infections of the eye,
* persons with a tear film break up time of less than 5 sec.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haag-Streit AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Goldblum, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Clinical Trial ES 900 - 2019
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1023707
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.